Repurchase of 2029 and 2030 convertible notes
Company: IREN
The claim, verbatim
IREN expects to enter into privately negotiated transactions to repurchase a portion of its 3.25% convertible senior notes due 2030 and 3.50% convertible senior notes due 2029, with aggregate repurchase amount expected to approximate the gross proceeds from the Concurrent Equity Offering
Source (primary)
iren 8-K exhibit (ny20060080x2_ex99-1.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-25)Live source ↗
Quote: “IREN expects to enter into one or more separate, privately negotiated transactions with a limited number of holders of IREN's outstanding 3.25% convertible senior notes due 2030... and 3.50% convertible senior notes due 2029... to repurchase a portion of the Existing 2030 Convertible Notes and a portion of the Existing 2029 Convertible Notes... in an aggregate amount expected to approximate the size of the Concurrent Equity Offering”
How we checked this
Checked on September 27, 2026. The cited source supports every part of this claim.
The press release states IREN expects privately negotiated repurchases of portions of both existing note series. It says the aggregate amount is expected to approximate the size of the concurrent equity offering.
Confirmed in the source:
- IREN expects to enter into one or more privately negotiated transactions with a limited number of holders of its existing convertible notes
- The transactions would repurchase a portion of IREN's 3.25% convertible senior notes due 2030
- The transactions would repurchase a portion of IREN's 3.50% convertible senior notes due 2029
- The aggregate repurchase amount is expected to approximate the size of the Concurrent Equity Offering, whose gross proceeds are expected to approximate the repurchase's cash consideration
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1878848/000114036125043803/ny20060080x2_ex99-1.htm) in full (15,338 characters, retrieved September 25, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms iren 8-K exhibit (ny20060080x2_ex99-1.htm)
Quote: “IREN expects to enter into one or more separate, privately negotiated transactions with a limited number of holders of IREN's outstanding 3.25% convertible senior notes due 2030... and 3.50% convertible senior notes due 2029... to repurchase a portion of the Existing 2030 Convertible Notes and a portion of the Existing 2029 Convertible Notes... in an aggregate amount expected to approximate the size of the Concurrent Equity Offering”